<DOC>
	<DOC>NCT01737424</DOC>
	<brief_summary>To investigate the safety, tolerability and pharmacokinetic characteristics of LC28-0126 in healthy male subjects</brief_summary>
	<brief_title>Study to Investigate the Safety and Pharmacokinetic Characteristics of LC28-0126 in Healthy Male Subjects</brief_title>
	<detailed_description />
	<criteria>Healthy male subjects between the ages of 20 and 45 years at screening. Subjects with BMI between 18.0(inclusive) and 27.0 kg/m2 (exclusive); and a total body weight between 55 kg (inclusive) and 90 kg (exclusive) Participation in a clinical research study within the previous 2 months Regular alcohol consumption &gt;21 units per week.</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2014</verification_date>
</DOC>